Takeda Pharmaceutical Company Limited (TAK)
NYSE·Healthcare·Drug Manufacturers - Specialty & Generic
$15.95
+0.50%
Mkt Cap $57.09B
No analyst coverage available
We don't have analyst ratings or price target data for Takeda Pharmaceutical Company Limited yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.